|
1
|
Oda Y, Miyajima K, Kawaguchi K, Tamiya S,
Oshiro Y, Hachitanda Y, Oya M, Iwamoto Y and Tsuneyoshi M:
Pleomorphic leiomyosarcoma: clinicopathologic and
immunohistochemical study with special emphasis on its distinction
from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am
J Surg Pathol. 25:1030–1038. 2001. View Article : Google Scholar
|
|
2
|
Nicolas MM, Tamboli P, Gomez JA and
Czerniak BA: Pleomorphic and dedifferentiated leiomyosarcoma:
clinicopathologic and immunohistochemical study of 41 cases. Hum
Pathol. 41:663–671. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mertens F, Fletcher CD, Dal Cin P, De
Wever I, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R,
Tallini G, et al: Cytogenetic analysis of 46 pleomorphic soft
tissue sarcomas and correlation with morphologic and clinical
features: a report of the CHAMP Study Group. Genes Chromosomes
Cancer. 22:16–25. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mandahl N, Fletcher CD, Dal Cin P, De
Wever I, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R,
Tallini G, et al: Comparative cytogenetic study of spindle cell and
pleomorphic leiomyosarcomas of soft tissues: a report from the
CHAMP Study Group. Cancer Genet Cytogenet. 116:66–73. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sandberg AA: Updates on the cytogenetics
and molecular genetics of bone and soft tissue tumors:
leiomyosarcoma. Cancer Genet Cytogenet. 161:1–19. 2005. View Article : Google Scholar
|
|
6
|
El-Rifai W, Sarlomo-Rikala M, Knuutila S
and Miettinen M: DNA copy number changes in development and
progression in leiomyosarcomas of soft tissues. Am J Pathol.
153:985–990. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang R, Lu YJ, Fisher C, Bridge JA and
Shipley J: Characterization of chromosome aberrations associated
with soft-tissue leiomyosarcomas by twenty-four-color karyotyping
and comparative genomic hybridization analysis. Genes Chromosomes
Cancer. 31:54–64. 2001. View
Article : Google Scholar
|
|
8
|
Derré J, Lagacé R, Nicolas A, Mairal A,
Chibon F, Coindre JM, Terrier P, Sastre X and Aurias A:
Leiomyosarcomas and most malignant fibrous histiocytomas share very
similar comparative genomic hybridization imbalances: an analysis
of a series of 27 leiomyosarcomas. Lab Invest. 81:211–215.
2001.
|
|
9
|
Evans HL and Shipley J: Leiomyosarcoma.
World Health Organization Classification of Tumours: Pathology and
Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni KK
and Mertens F: IARC Press; Lyon: pp. 131–134. 2002
|
|
10
|
Wang R, Titley JC, Lu YJ, Summersgill BM,
Bridge JA, Fisher C and Shipley J: Loss of 13q14-q21 and gain of
5p14-pter in the progression of leiomyosarcoma. Mod Pathol.
16:778–785. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu J, Rao UN, Jasani S, Khanna V, Yaw K
and Surti U: Loss of DNA copy number of 10q is associated with
aggressive behavior of leiomyosarcomas: a comparative genomic
hybridization study. Cancer Genet Cytogenet. 161:20–27. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Larramendy ML, Kaur S, Svarvar C, Böhling
T and Knuutila S: Gene copy number profiling of soft-tissue
leiomyosarcomas by array-comparative genomic hybridization. Cancer
Genet Cytogenet. 169:94–101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J, Du X, Chen K, Ylipää A, Lazar AJ,
Trent J, Lev D, Pollock R, Hao X, Hunt K and Zhang W: Genetic
aberrations in soft tissue leiomyosarcoma. Cancer Lett. 275:1–8.
2009. View Article : Google Scholar
|
|
14
|
Nishio J, Aoki M, Nabeshima K, Iwasaki H
and Naito M: Cytogenetic and molecular cytogenetic findings in
giant dedifferentiated liposarcoma of the thigh. Oncol Rep.
27:764–768. 2012.PubMed/NCBI
|
|
15
|
Shaffer LG, Slovak ML and Campbell LJ:
ISCN (2009): An International System for Human Cytogenetic
Nomenclature. Karger; Basel: 2009
|
|
16
|
Nishio J, Iwasaki H, Althof PA, Naumann S,
Ishiguro M, Haraoka S, Iwashita A, Iwasaki A, Kaku Y, Kaneko Y, et
al: Identification of a ring chromosome with spectral karyotyping
in a pleural synovial sarcoma. Cancer Genet Cytogenet. 160:174–178.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishio J, Iwasaki H, Ohjimi Y, Ishiguro M,
Koga T, Isayama T, Naito M and Kikuchi M: Gain of Xq detected by
comparative genomic hybridization in elastofibroma. Int J Mol Med.
10:277–280. 2002.PubMed/NCBI
|
|
18
|
Fletcher CDM: Pleomorphic malignant
fibrous histiocytoma: fact or fiction? A critical reappraisal based
on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol.
16:213–218. 1992. View Article : Google Scholar
|
|
19
|
Chen E, O’Connell F and Fletcher CDM:
Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18
cases. Histopathology. 59:1135–1143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishio J: Contributions of cytogenetics
and molecular cytogenetics to the diagnosis of adipocytic tumors. J
Biomed Biotechnol. 2011:5240672011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Otaño-Joos M, Mechtersheimer G, Ohl S,
Wilgenbus KK, Scheurlen W, Lehnert T, Willeke F, Otto HF, Lichter P
and Joos S: Detection of chromosomal imbalances in leiomyosarcoma
by comparative genomic hybridization and interphase cytogenetics.
Cytogenet Cell Genet. 90:86–92. 2000.PubMed/NCBI
|
|
22
|
Levy B, Mukherjee T and Hirschhorn K:
Molecular cytogenetic analysis of uterine leiomyoma and
leiomyosarcoma by comparative genomic hybridization. Cancer Genet
Cytogenet. 121:1–8. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu J, Khanna V, Jones M and Surti U:
Genomic alterations in uterine leiomyosarcomas: potential markers
for clinical diagnosis and prognosis. Genes Chromosomes Cancer.
31:117–124. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gisselsson D, Björk J, Höglund M, Mertens
F, Dal Cin P, Akerman M and Mandahl N: Abnormal nuclear shape in
solid tumors reflects mitotic instability. Am J Pathol.
158:199–206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iwasaki H, Nabeshima K, Nishio J, Jimi S,
Aoki M, Koga K, Hamasaki M, Hayashi H and Mogi A: Pathology of
soft-tissue tumors: daily diagnosis, molecular cytogenetics and
experimental approach. Pathol Int. 59:501–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gisselsson D, Jonson T, Petersén A,
Strömbeck B, Dal Cin P, Höglund M, Mitelman F, Mertens F and
Mandahl N: Telomere dysfunction triggers extensive DNA
fragmentation and evolution of complex chromosome abnormalities in
human malignant tumors. Proc Natl Acad Sci USA. 98:12683–12688.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Forus A, Weghuis DO, Smeets D, Fodstad O,
Myklebost O and van Kessel AG: Comparative genomic hybridization
analysis of human sarcomas: I. Occurrence of genomic imbalances and
identification of a novel major amplicon at 1q21-q22 in soft tissue
sarcomas. Genes Chromosomes Cancer. 14:8–14. 1995. View Article : Google Scholar
|
|
28
|
Nilsson M, Meza-Zepeda LA, Mertens F,
Forus A, Myklebost O and Mandahl N: Amplification of chromosome 1
sequences in lipomatous tumors and other sarcomas. Int J Cancer.
109:363–369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Forus A, D’Angelo A, Henriksen J, Merla G,
Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda
LA, del Vecchio Blanco F, et al: Amplification and overexpression
of PRUNE in human sarcomas and breast carcinomas - a possible
mechanism for altering the nm23-H1 activity. Oncogene.
20:6881–6890. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ragazzini P, Gamberi G, Pazzaglia L, Serra
M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M,
Bertoni F, et al: Amplification of CDK4, MDM2, SAS and GLI genes in
leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol
Histopathol. 19:401–411. 2004.PubMed/NCBI
|
|
31
|
Meza-Zepeda LA, Kresse SH,
Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namløs HM, Wang J,
Kristiansen BE and Myklebost O: Array comparative genomic
hybridization reveals distinct DNA copy number differences between
gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res.
66:8984–8993. 2006. View Article : Google Scholar
|
|
32
|
Pérot G, Derré J, Coindre JM, Tirode F,
Lucchesi C, Mariani O, Gibault L, Guillou L, Terrier P and Aurias
A: Strong smooth muscle differentiation is dependent on myocardin
gene amplification in most human retroperitoneal leiomyosarcomas.
Cancer Res. 69:2269–2278. 2009.PubMed/NCBI
|
|
33
|
Du KL, Ip HS, Li J, Chen M, Dandre F, Yu
W, Lu MM, Owens GK and Parmacek MS: Myocardin is a critical serum
response factor cofactor in the transcriptional program regulating
smooth muscle cell differentiation. Mol Cell Biol. 23:2425–2437.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Z, Wang DZ, Pipes GC and Olson EN:
Myocardin is a master regulator of smooth muscle gene expression.
Proc Natl Acad Sci USA. 100:7129–7134. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pipes GC, Creemers EE and Olson EN: The
myocardin family of transcriptional coactivators: versatile
regulators of cell growth, migration, and myogenesis. Genes Dev.
20:1545–1556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gill S, Stratton MR, Patterson H, Spurr
NK, Fisher C, Gusterson BA and Cooper CS: Detection of transforming
genes by transfection of DNA from primary soft-tissue tumours.
Oncogene. 6:1651–1656. 1991.PubMed/NCBI
|
|
37
|
Pryor JG, Brown-Kipphut BA, Iqbal A and
Scott GA: Microarray comparative genomic hybridization detection of
copy number changes in desmoplastic melanoma and malignant
peripheral nerve sheath tumor. Am J Dermatopathol. 33:780–785.
2011. View Article : Google Scholar
|
|
38
|
Bellavia D, Checquolo S, Campese AF, Felli
MP, Gulino A and Screpanti I: Notch3: from subtle structural
differences to functional diversity. Oncogene. 27:5092–5098. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Choong PF, Mandahl N, Mertens F, Willén H,
Alvegård T, Kreicbergs A, Mitelman F and Rydholm A: 19p+ marker
chromosome correlates with relapse in malignant fibrous
histiocytoma. Genes Chromosomes Cancer. 16:88–93. 1996.
|
|
40
|
Larramendy ML, Gentile M, Soloneski S,
Knuutila S and Böhling T: Does comparative genomic hybridization
reveal distinct differences in DNA copy number sequence patterns
between leiomyosarcoma and malignant fibrous histiocytoma? Cancer
Genet Cytogenet. 187:1–11. 2008. View Article : Google Scholar
|
|
41
|
Dei Tos AP, Maestro R, Doglioni C,
Piccinin S, Libera DD, Boiocchi M and Fletcher CDM: Tumor
suppressor genes and related molecules in leiomyosarcoma. Am J
Pathol. 148:1037–1045. 1996.PubMed/NCBI
|
|
42
|
Hernando E, Charytonowicz E, Dudas ME,
Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L,
Maki RG, et al: The AKT-mTOR pathway plays a critical role in the
development of leiomyosarcomas. Nat Med. 13:748–753. 2007.
View Article : Google Scholar : PubMed/NCBI
|
